Sickle Cell Disease Undergoes in Medicine / Internal Medicine — 22yo Man | Infectious Diseases | SMLE Q#17611
SMLE Question #17611
Medicine / Internal Medicine
Infectious Diseases
Objective: OBJ-NEUTRO-001
Last updated: February 2026
A 22-year-old man with sickle cell disease undergoes an allogeneic hematopoietic stem cell transplant. On post-transplant day 1, he develops fever and chills and is started on empiric IV ceftazidime for high-risk neutropenic fever. After 72 hours, he remains febrile with no clinical improvement. Examination now shows erythema and tenderness at his central venous catheter insertion site. Blood and urine cultures to date show no growth. Which additional antibiotic should be added to his regimen?
Continue in practice mode
Sign in and start a focused practice session to view options, submit your answer, and read the full explanation.